Clinical Trial Site

Bonn 53127

1 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, End Stage Renal Disease, Genetic Disease, Human Immunodeficiency Virus (HIV)-1 Infection, Kidney Diseases, Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2, Primary Hyperoxaluria Type 2 (PH2), Primary Hyperoxaluria Type 3, Primary Hyperoxaluria Type 3 (PH3)

Studies at this site

• Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD — Recruiting now
• Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function — Completed
• A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery — Completed
• Long Term Extension Study in Patients With Primary Hyperoxaluria — Running, not enrolling
• A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 — Completed
• Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients — Completed
• A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1 — Completed
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed
• Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A — Completed
• Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery — Stopped early